← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Marker Therapeutics MRKR $17.7M	60	+2	+3%	$20.4M
52	LOGC 52 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	59	+8	+16%	$133M
53	53 DELISTED Carisma Therapeutics CARM	56	+11	+24%	$37.3M
54	GMDA 54 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	56	+18	+47%	$230M
55	55 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	56	+4	+8%	$288M
56	56 Cabaletta Bio CABA $242M	55	+1	+2%	$202M
57	57 Mesoblast MESO $1.72B	53	+2	+4%	$24.3M
58	58 4D Molecular Therapeutics FDMT $682M	52	+52	–	$602M
59	59 Taysha Gene Therapies TSHA $1.18B	51	+5	+11%	$475M
60	60 Autolus Therapeutics AUTL $429M	48	+2	+4%	$113M
61	61 Pluri PLUR $12.2M	46	-6	-12%	$37.7M
62	PTE 62 DELISTED PolarityTE, Inc. Common Stock PTE	46	+5	+12%	$6.32M
63	SGTX 63 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	45	+45	–	$942M
64	64 Adicet Bio ACET $44M	44	+12	+38%	$134M
65	65 Ocugen OCGN $271M	43	+24	+126%	$26.6M
66	66 Immatics IMTX $1.04B	41	-3	-7%	$216M
67	67 Lunai Bioworks LNAI $3.54M	40	+1	+3%	$7.22M
68	68 DELISTED Orgenesis Inc. Common Stock ORGS	37	-2	-5%	$19.4M
69	SQZ 69 DELISTED SQZ Biotechnologies Company SQZ	36	+36	–	$234M
70	BLCM 70 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	34	+12	+55%	$5.76M
71	ONCS 71 DELISTED OncoSec Medical Incorporated ONCS	31	+6	+24%	$27.4M
72	72 Genprex GNPX $1.79M	28	+6	+27%	$28.8M
73	73 INmune Bio INMB $44.4M	26	-2	-7%	$15M
74	74 Capricor Therapeutics CAPR $392M	25	0	0%	$5.14M
75	75 Imunon IMNN $5.89M	25	-9	-26%	$2.28M